New insights into HER2-low breast cancer brain metastasis: A retrospective analysis.

Breast · 2024 · PMC10791565 · PMID 38176304

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

Based on our institute's database, other two studies have identified a clear trend of improved OS and 5-year DFS in HER2-low patients, with notable variations observed within the HR-positive group [ 30 , 31 ].

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.